Trials / Unknown
UnknownNCT05053893
Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome
A Randomized, Parallel Controlled Trial of Roxadustat Combined withSacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- The Affiliated Hospital of Qingdao University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A randomized and parallel controlled trial design of comparing the new treatment group of Roxadustat combined with Sacubitril Valsartan Sodium Tablets with the traditional treatment group of recombinant human erythropoietin (EPO) combined with ACEI or ARB in Chinese patients with cardiorenal anemia syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Roxadustat;Sacubitril Valsartan Sodium Tablets; | Select the appropriate dose according to the patient's situation |
| DRUG | EPO; ACEI / ARB | Select the appropriate ACEI /ARB according to the subject's situation or follow its previous medication |
Timeline
- Start date
- 2021-09-22
- Primary completion
- 2022-07-01
- Completion
- 2022-09-01
- First posted
- 2021-09-23
- Last updated
- 2021-09-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05053893. Inclusion in this directory is not an endorsement.